Brief: 4D Molecular Therapeutics Announces Pricing Of Upsized Public Offering Of Common Stock
05/05/2023 02:07
May 4 (Reuters) - 4D Molecular Therapeutics Inc
FDMT.O :
* 4D MOLECULAR THERAPEUTICS ANNOUNCES PRICING OF UPSIZED
PUBLIC
OFFERING OF COMMON STOCK
* PRICED AN UPSIZED UNDERWRITTEN PUBLIC OFFERING OF 7.5
MILLION
SHARES AT PUBLIC OFFERING PRICE OF $16.00 PER SHARE
Source text for Eikon: ID:nGNX3BLlpl
Further company coverage: FDMT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 4D Molecular Therapeutics
See all news4D Molecular Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
4D Molecular Therapeutics Q2 net loss widens
Brief: 4D Molecular Therapeutics Q2 Net Income USD -72.936 Million Vs. IBES Estimate USD -70.3 Million
4D Molecular Therapeutics Inc expected to post a loss of $1.02 a share - Earnings Preview
Brief: 4d Molecular Therapeutics Says 4D-150 Continues To Be Well Tolerated With No New Safety Findings